Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Moseley Investment Management Inc.

Moseley Investment Management Inc. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,139 shares of the medical equipment provider’s stock after buying an additional 51 shares during the period. Moseley Investment Management Inc.’s holdings in Intuitive Surgical were worth $1,116,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Wealthspire Advisors LLC lifted its position in Intuitive Surgical by 10.9% in the second quarter. Wealthspire Advisors LLC now owns 1,145 shares of the medical equipment provider’s stock worth $509,000 after purchasing an additional 113 shares during the period. Brown Brothers Harriman & Co. raised its stake in shares of Intuitive Surgical by 45.3% in the 2nd quarter. Brown Brothers Harriman & Co. now owns 2,228 shares of the medical equipment provider’s stock worth $991,000 after buying an additional 695 shares in the last quarter. Angeles Investment Advisors LLC acquired a new stake in shares of Intuitive Surgical in the second quarter valued at $221,000. Dimensional Fund Advisors LP boosted its stake in Intuitive Surgical by 10.2% during the second quarter. Dimensional Fund Advisors LP now owns 572,934 shares of the medical equipment provider’s stock valued at $254,872,000 after buying an additional 52,976 shares in the last quarter. Finally, One Capital Management LLC acquired a new position in Intuitive Surgical during the second quarter worth about $790,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at $3,638,990. This trade represents a 26.54 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 48,190 shares of company stock valued at $25,012,927 in the last quarter. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ISRG. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Piper Sandler reissued an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Truist Financial lifted their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Leerink Partners upped their price target on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Finally, Mizuho raised their price objective on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $538.88 on Wednesday. The stock has a market cap of $191.94 billion, a PE ratio of 86.64, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $355.17 and a fifty-two week high of $556.23. The stock’s 50-day moving average is $537.05 and its two-hundred day moving average is $496.50.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.